Clinical trial Recruiting at 1 site Phase1; Phase2 Interventional Ages 18 to 45 Women only

Effects of bariatric surgery on Drospirenone pill absorption

Official title: Pharmacokinetics of Drospirenone Only Pills in Obese Thai Women: A Pre- and Post-Bariatric Surgery Study

Run by Chulalongkorn University · NCT06345560 · Data updated 2026-11-12

This study is testing how bariatric surgery affects how well Drospirenone birth control pills work in obese women.

More Contraception trials

Quick facts

PhasePhase1; Phase2
Study typeInterventional
Ages18 Years to 45 Years
SexWomen only
Enrollment16 (estimated)
SponsorChulalongkorn University
Academic / other
Locations1 site (Bangkok)
StatusRecruiting
StartedApril 18, 2024
Main results expectedJuly 2026
Study endsJuly 2026
Registry record updatedMarch 19, 2026
Trial IDNCT06345560 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Thai women aged 18-45 who are obese and scheduled for bariatric surgery, requiring contraception.

Probably not a fit

Patients who are pregnant, breastfeeding, or have contraindications to Drospirenone will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates how bariatric surgery impacts the absorption of Drospirenone-only pills in obese women. Participants will take the pills daily, and their pharmacokinetics will be measured before and after the surgery. The goal is to understand any changes in how the body processes the medication due to surgical weight loss. This could provide important insights into contraceptive effectiveness in this population.

Why it matters

Potential benefit: If successful, this study could improve contraceptive options and effectiveness for women undergoing bariatric surgery.

How similar studies have gone: While studies on pharmacokinetics in bariatric surgery patients exist, this specific focus on Drospirenone is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Thai women aged 18-45 years who are obese and had an appointment for Bariatric surgery at Chulalongkorn Hospital
* Need contraception
* Able to use non-hormonal contraception during the study
* Giving consent

Exclusion Criteria:

* Pregnancy or history of giving birth within 3 months
* Breastfeeding within the 6 months
* History of using DMPA within 12 months
* History of using other types of hormonal birth control pills within 4 weeks
* History of bilateral oophorectomy or hysterectomy
* Suspected ovarian tumor or pathological ovarian cyst
* Regular cigarette smoking
* Contraindications to Drospirenone

Where it's running

  • Chulalongkorn University
    Bangkok, Thailand
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.